Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Depreciation & Amortization (CF) (2019 - 2025)

Biodesix (BDSX) has disclosed Depreciation & Amortization (CF) for 7 consecutive years, with $1.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) fell 4.21% year-over-year to $1.4 million, compared with a TTM value of $5.7 million through Dec 2025, down 1.8%, and an annual FY2025 reading of $5.7 million, down 1.78% over the prior year.
  • Depreciation & Amortization (CF) was $1.4 million for Q4 2025 at Biodesix, down from $1.4 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $1.5 million in Q3 2024 and bottomed at $746000.0 in Q1 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $1.1 million, with a median of $903000.0 recorded in 2022.
  • The sharpest move saw Depreciation & Amortization (CF) decreased 13.55% in 2023, then soared 90.92% in 2024.
  • Year by year, Depreciation & Amortization (CF) stood at $855000.0 in 2021, then rose by 5.03% to $898000.0 in 2022, then increased by 8.8% to $977000.0 in 2023, then soared by 48.31% to $1.4 million in 2024, then dropped by 4.21% to $1.4 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for BDSX at $1.4 million in Q4 2025, $1.4 million in Q3 2025, and $1.4 million in Q2 2025.